S02 - RFQ 0002 Questions Answers and SOW Updates.pdf
PDF 161 KB Posted
- Attached to
- 6550--Blood Bank Automation CPT Solution
- Solicitation number
- 36C26224Q1272
About this file
This document contains questions and answers related to a Request for Quote (RFQ) for a Blood Bank Automation CPT Solution. The RFQ is solicited by the Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 22.
The key details include:
- Clarification on the volumes for patient forward/reverse typing, donor retype, Rh phenotype, and non-Rh antigen typing for various locations.
- Confirmation of the antibody screen type (2-cell or 3-cell) and automated Rh phenotyping assays used at each location.
- Details on the Direct Antiglobulin Test (DAT) methodology (Polyspecific or IgG) used at each location.
- Updates to the Statement of Work, including revised sections on sensitivity validation, specificity studies, and verifying expected ABO and negative screen reactions.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26224Q1272 0005_1.docx | DOCX document | |
| S02 - RFQ 36C26224Q1272 0005 SF30.pdf | ||
| 36C26224Q1272 0004_1.docx | DOCX document | |
| S02 - RFQ 36C26224Q1272 0004 SF30.pdf | ||
| S02 - RFQ 36C26224Q1272 0003 SF30.pdf | ||
| 36C26224Q1272 0003_1.docx | DOCX document | |
| S02 - RFQ 0002 36C26224Q1272 SF30.pdf | ||
| 36C26224Q1272 0002_1.docx | DOCX document | |
| 36C26224Q1272 0001_1.docx | DOCX document | |
| Amendment 0001 36C26224Q1272.pdf | ||
| S02 - Attachment B - 6500.6 Handbook Appendix C.pdf | ||
| 36C26224Q1272_1.docx | DOCX document | |
| S02 - RFQ 36C26224Q1272.docx | DOCX document | |
| S02 - Attachment A - Blood Bank Pricing Sched 5yrs.xlsx | XLSX spreadsheet |
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
QUESTIONS:
Please clarify if “ABO/Rh confirmation” testing is for patients forward and reverse typing or for donor retype forward typing only? If it includes both, please indicate separately the volumes for each.
Please clarify which sites are using a 2 cell Antibody screen or 3 cell Antibody screen.
How many antigen typing’s are for Rh typing? Other antigens?
How many Crossmatches are IgG and how many immediate spin (IS)?
Is the Direct Antiglobulin Test performed using Polyspecific (Anti-IgG,-C3) or Anti-IgG? How many of each?
PLEASE VIEW BELOW FOR ANSWERS
Volume Clarfication ABQ GLA LB LL PHX PRE SD TUC
Patients forward and reverse typing
1920 (only mnual) automated, 462 manual automated, 500 manual automated, 170 manual
237 (only manual) 3154 1134
Donor retype 1015 (only manual) automated, 47 manual
1500 (usually manual) autoamted, 35 manual
420 (only manual) 1477 156
Rh phenotype (specify which antigen and volume if multiple present):
C 25, c 10, E
35, e 5 (only manual)
E= 40, e=25, C=40, c= 20
(only manual)
126 (only manual)
75 (only manual) automated
(C, c, E, e..all run together)
Not performed currently
C15, c15, E15, e15
488 (Rh typing is automated on the card.
It’s all CcEe)
Non Rh antigen typing 85 (only manual)
176 (only manual)
75 (only manual)
90 (only manual)
Not performed currently
66 (only manual)
275 (only manual)
IgG Crossmatches 360 (only manual) automated, 93 manual
850 (usually manual)
225 (only manual)
75 (only manual) automated, 52 manual
IS Crossmatches 60 (only manual) 3600 1958 eXM
25 (only manual)
23 (only manual)
165 (only manual)
7 (only manual)
62 (only manual)
Poly DAT
75 patient 65
QC (only manual)
100 79 375 (only manual) 0 23 175 68
IgG DAT
15 patient
(only manual)
40 40 300 (only manual)
Not performed currently
10 (only manual)
Assay Clarification ABQ GLA LB LL PHX PRE SD TUC
Do you use a 2 cell Antibody screen or 3 cell Antibody screen?
2 cell
Antibody
Screen
3 cell
Antibody
Screen
3 cell
Antibody
Screen
3 cell
Antibody
Screen
3 cell
Antibody
Screen
2 cell
Antibody
Screen
2 cell
Antibody
Screen
3 cell
Antibody
Screen
What automated Rh phenotyping assays are you using?
None None None None
Anti‐E and Rh
Phenotype
(Card consists of Anti‐D, Anti‐C, Anti‐ c, Anti‐E, Anti‐ e, Control)
None
ID‐MTS Gel
Rh
Monoclonal
Phenotype
Card (C,c,E,e)
Ortho
Monoclonal
Rh
Phenotype
Card
What automated Rh phenotyping assays are you wanting?
None None C/c, E/e
If Rh only antigen phenotyping available on instrument, then none.
Anti‐E and Rh
Phenotype
(Card consists of Anti‐D, Anti‐C, Anti‐ c, Anti‐E, Anti‐ e, Control)
DCEce None N/A
What type of DAT is used
(Poly vs IgG)
Poly (IgG+‐
C3d), confirm positives with IgG and
Complement.
Poly first then if positive IgG and C3d
Both
Poly first then if positive IgG and C3d
IgG and
C3b/d Poly Poly Poly, IgG, C3d
UPDATE TO THE STATEMENT OF WORK
SOW is updated as follows:
Sections 7.3, 7.4 and 7.5 now read:
7.3 Sensitivity may be validated.
7.4 Specificity Studies. A review of product literature and assay inserts to determine any adverse effects for increased bilirubin, hemolysis, lipemia, or other interfering substances.
7.5. A minimum of 20 reference individuals shall be used to verify reactivity of expected ABO and negative screen reactions. Any apparent outliers should be discarded, and new specimens obtained to provide a statistically valid verification.
Sections 7.6 and 7.7 are not relevant and no longer part of the SOW.
File details come from the government source that posted it. Updated .